Precellys®24: Disruption and lysis of even toughest samples within seconds
Homogenisers Precellys®24 and Precellys®24-Dual from PEQLAB
Request information
Precellys®24: Disruption and lysis of even toughest samples within seconds
Homogenisers Precellys®24 and Precellys®24-Dual from PEQLAB
More videos from Peqlab Biotechnologie
More videos on similar topics

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Last viewed contents
Neovacs’ Second Kinoid enters clinical testing - Initiation of Phase I/II study of IFNalpha Kinoid in lupus patients
How Cells Tolerate DNA Damage - MDC Researchers Identify Start Signal for Cell Survival Program
Combined resistance to multiple antibiotics: A growing problem in the EU
Holocarboxylase_synthetase_deficiency
Vipera_seoanei

Preventing asthma in children: University of Arizona researchers are 1 step closer
5 Leading Multinationals Announce R&D Projects for Ireland - Bristol-Myers Squibb Company, Pfizer Inc., Genzyme Corporation, Xilinx Inc. Citigroup are investing a total of EUR 53.25 million
